Neurological diseases, particularly in the context of aging, have serious impacts on quality of
life and can negatively affect bone health. The brain-bone axis is critically important for …

Identifying a reliable biomarker may accelerate diagnosis of multiple sclerosis (MS) and lead
to early management of the disease. Accumulating evidence suggest that cerebrospinal fluid …

Fractures resulting from osteoporosis are a major cause of morbidity and mortality in the
developed world. People with multiple sclerosis experience reduced mobility and are …

Multiple sclerosis (MS) is a chronic inflammatory-demyelinating disease of the nervous
system. There has been mounting evidence showing that MS is associated with increased …

Background: The cytokine osteopontin (OPN) is a potential key player in the
immunopathogenesis of multiple sclerosis (MS) and a candidate biomarker for disease …

Objective: Osteoporosis is common in patients with multiple sclerosis (MS) with long-
standing disease. Hypovitaminosis D is a candidate risk factor for MS, and vitamin D also …

People who are disabled with multiple sclerosis (MS) may be at increased risk of
osteoporosis. This review discusses issues relevant to bone health in MS and makes …

The implications of having multiple sclerosis (MS) for bone health are incompletely
understood. The aim of this population-based study is to identify past and current exposures …

Multiple sclerosis (MS) is associated with reduced bone mass and higher frequency of
osteoporosis. Although high-dose short-term intravenous glucocorticoid regimens cause a …

Background Patients with multiple sclerosis (MS) are at increased risk of osteoporosis and
fractures. Adipose tissue-derived adipokines may play important roles in the …